TIM shares slide as reported grid bids disappoint
..
Headlines
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

..
Headlines

Investors are particularly interested in GSK’s future plans, given the pending loss of patent protection in 2027 for dolutegrav..
Headlines